Cargando…
Ginsenoside Re inhibits myocardial fibrosis by regulating miR-489/myd88/NF-κB pathway
BACKGROUND: Myocardial fibrosis (MF) is an advanced pathological manifestation of many cardiovascular diseases, which can induce heart failure and malignant arrhythmias. However, the current treatment of MF lacks specific drugs. Ginsenoside Re has anti-MF effect in rat, but its mechanism is still no...
Autores principales: | Sun, Jinghui, Wang, Ru, Chao, Tiantian, Peng, Jun, Wang, Chenglong, Chen, Keji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014187/ https://www.ncbi.nlm.nih.gov/pubmed/36926602 http://dx.doi.org/10.1016/j.jgr.2021.11.009 |
Ejemplares similares
-
miR-489 inhibits silica-induced pulmonary fibrosis by targeting MyD88 and Smad3 and is negatively regulated by lncRNA CHRF
por: Wu, Qiuyun, et al.
Publicado: (2016) -
Inhibition of Mogroside IIIE on isoproterenol-induced myocardial fibrosis through the TLR4/MyD88/NF-κB signaling pathway
por: Yanan, Shi, et al.
Publicado: (2023) -
Ginsenoside Rg3 treats acute radiation proctitis through the TLR4/MyD88/NF-κB pathway and regulation of intestinal flora
por: Duan, Xiaoyu, et al.
Publicado: (2023) -
Phycocyanin attenuates pulmonary fibrosis via the TLR2-MyD88-NF-κB signaling pathway
por: Li, Chengcheng, et al.
Publicado: (2017) -
LuQi Formula Ameliorates Myocardial Fibrosis by Suppressing TLR4/MyD88/NF-κB Pathway and NLRP3 Inflammasome Activation in Mice with Myocardial Infarction
por: Zhang, Xiaoqing, et al.
Publicado: (2022)